October 29, 2018
Within a few years, Jim Johnsen and Delaney Van Riper may be among the first to benefit from CRISPR-Cas9 gene editing, a breakthrough that has already revolutionized biology research and promises to resurrect gene therapy. UC San Francisco doctors working closely with UC Berkeley scientists plan to edit their genomes […]
